(Q38551543)

4 September 2017

0 references

1 reference

title

Antiviral Therapy in Steroid-refractory Ulcerative Colitis with Cytomegalovirus: Systematic Review and Meta-analysis (English)

1 reference

4 September 2017

0 references

1 reference

1 reference

1 reference

3

Edward V Loftus

1 reference

4 September 2017

Tushar Shukla

1

1 reference

4 September 2017

Siddharth Singh

series ordinal

2

1 reference

4 September 2017

David H Bruining

series ordinal

4

1 reference

4 September 2017

Jeffrey D McCurdy

series ordinal

5

1 reference

4 September 2017

publication date

20 July 2015

1 reference

Inflammatory Bowel Diseases

4 September 2017

published in

1 reference

4 September 2017

volume

21

1 reference

4 September 2017

issue

11

1 reference

4 September 2017

page(s)

2718-2725

1 reference

A model for identifying cytomegalovirus in patients with inflammatory bowel disease

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Antiviral therapy in cytomegalovirus-positive ulcerative colitis: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

GRADE guidelines: 7. Rating the quality of evidence--inconsistency

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Cytomegalovirus positive ulcerative colitis: A single center experience and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

The absence of large ulcer predicts latent cytomegalovirus infection in ulcerative colitis with positive mucosal viral assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Combined-modality therapy in locally advanced primary rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000489

10.1097/MIB.0000000000000489

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference